Internal vs. Independent Investigations: When Should Healthcare and Life Sciences Companies Bring in Outside Counsel?

When a compliance issue arises, organizations typically begin by addressing it internally through compliance, legal, or HR. That instinct is often appropriate. Internal teams understand the business, have access to information, and can respond quickly.

For routine matters, that approach works. Internal teams are well positioned to handle issues that are limited in scope and do not raise broader regulatory concerns. An isolated billing discrepancy, a minor policy deviation, or an employee conduct issue with no indication of a wider pattern can often be resolved internally. The objective in those situations is straightforward. Understand what happened, document the outcome, and implement corrective action. But not all compliance issues are the same. As exposure increases, the analysis changes in ways that affect how an investigation should be structured and who should lead it.

The Structural Limits of Internal Investigations

Even when internal teams act in good faith, they operate within the organization. Reporting lines, professional relationships, and institutional dynamics can shape how an investigation is perceived. That is true regardless of whether those dynamics actually influence the outcome.

Perception matters in this context. The appearance of a conflict can carry as much weight as the conflict itself. Regulators and enforcement agencies are attuned to this distinction. The Department of Justice and HHS-OIG evaluate not only what an investigation found, but how it was conducted and by whom. An investigation that appears constrained or conflicted may carry less weight, even when the underlying analysis is sound.

Internal teams may also face practical constraints. Access to certain communications may be limited. Forensic capabilities may be narrower than what the situation requires. There may also be hesitation, however subtle, around pursuing findings that expose institutional risk. These are not failures of judgment, but rather, they are features of how organizations operate and are part of what regulators expect independent counsel to address.

When the Risk Profile Changes

Some issues require a different approach. That shift is not about whether internal teams are capable. It is about whether the circumstances allow internal capability to be sufficient. This threshold is often reached when an issue implicates regulatory frameworks, involves senior leadership, or presents the possibility of external scrutiny. At that point, the investigation becomes part of the organization’s broader response strategy. The focus is no longer limited to understanding what happened. It includes how the process will be viewed if it is examined by regulators, a court, or a counterparty.

Why Independence Matters

Independence affects both the process and how the results are received. An investigation conducted by outside counsel creates separation from internal reporting structures. That separation reduces concerns about objectivity and allows findings to carry more weight with regulators, courts, investors, and counterparties.

Independence also allows the investigation to be structured with privilege in mind. When conducted under the direction of counsel for the purpose of providing legal advice, the work is generally protected by attorney-client privilege. Internal investigations that are not carefully structured can risk exposing findings to discovery in government proceedings or parallel civil litigation. This is particularly relevant in healthcare and life sciences, where regulatory investigations and qui tam actions often run at the same time.

Situations That Often Warrant Outside Counsel

There is no single rule that applies across every situation, but certain circumstances consistently point toward involving outside counsel:

• Government contact is one of the clearest indicators. A subpoena, civil investigative demand, OIG inquiry, or even informal outreach from enforcement agencies should prompt immediate consideration of outside counsel. The government’s posture is rarely clear at the outset, and early missteps are difficult to unwind.

• Allegations involving senior leadership present similar concerns. When executives or individuals who oversee compliance functions are implicated, internal investigations raise structural credibility issues that can affect how findings are viewed.

• Whistleblower complaints that present potential False Claims Act exposure also require careful handling. These matters carry significant financial and regulatory consequences and often involve parallel proceedings.

• Other situations include concerns that suggest conduct may be systemic rather than isolated. These include matters involving potential criminal exposure, issues identified in transaction diligence, and investigations that require technical or forensic capabilities beyond what internal teams can provide.

In these situations, the issue is not whether internal teams are capable. It is whether the investigation will carry the level of credibility the circumstances require.

Privilege and the Disclosure Decision

One of the most important early decisions in any significant investigation is how it is structured. Investigations conducted under the direction of outside counsel are generally protected by attorney-client privilege. Internal investigations that are not structured carefully can risk waiver, which may expose findings to regulators or opposing parties in litigation.

This has practical consequences. Organizations should be cautious about beginning substantive investigative work, particularly witness interviews, before privilege structure is in place. Statements made without that framework can create exposure that is difficult to address later.

Privilege also affects the voluntary disclosure decision. Regulators such as HHS-OIG and DOJ treat self-disclosure as a mitigating factor, but only when it is supported by a credible and well-supported investigation. An internal review that is viewed as incomplete or constrained may undermine that process.

Taking a Practical Approach

The decision to involve outside counsel does not need to be made immediately in every situation. In many cases, the appropriate first step is an initial assessment. A structured evaluation of the concern and the potential level of regulatory risk can help determine whether the issue can be handled internally or whether a more formal investigation is warranted.

Timing matters. Delays in making that determination can limit options. Evidence becomes harder to preserve. Witness recollections change. Opportunities to structure the investigation properly narrow over time. Engaging outside counsel early does not signal wrongdoing. It reflects a considered approach to managing risk in situations where the stakes justify it.

Key Takeaways

• Internal investigations are appropriate for routine, low-risk, and clearly defined issues

• As regulatory exposure increases, independence becomes critical to credibility

• Regulators evaluate how an investigation was conducted and by whom, not only what it found

• Privilege should be addressed at the outset, before substantive investigative work begins

• Delays in engaging outside counsel can limit options and increase risk

Internal investigations serve an important role and are often the right starting point. But they require judgment about when that approach is no longer sufficient. That determination turns less on capability and more on structure, credibility, and how the investigation will be evaluated outside the organization.